Billions of prescriptions for generic drugs are filled in the U.S. annually. The FDA tests only a few dozen of them every ...

As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide injections are largely being phased out. While they may still be available ...

Ultimately, AI enables loyalty programs to operate at a micro, highly personalized level, using historical data to drive ...

Author Steven C. Smith talks about his absorbing new book, 'Hitchcock and Herrmann: The Friendship and Film Scores that ...

Health Canada's Pharmaceutical Drugs Directorate (PDD) and the U.S. Food and Drug Administration's (FDA) Office of Generic Drugs (OGD) have created a program to support the establishment of a Request ...

The shutdown brought the scale of the federal food aid program into focus and raised questions about how such a rich country could have so many people on nutrition assistance. By David W. Chen The ...

On October 3, 2025, the U.S. Food and Drug Administration (FDA) announced a prioritization pilot program for reviewing abbreviated new drug applications (ANDAs). ANDAs are submissions for generic ...

Abstract: Mobile Crowdsensing (MCS) has become a popular sensing paradigm, where a number of participants use their mobile devices to collectively share and extract information related to a certain ...

Rollercoaster Tycoon wasn’t the most fashionable computer game out there in 1999. But if you took a look beneath the pixels—the rickety rides, the crowds of hungry, thirsty, barfing people (and the ...

According to Nova One Advisor, the U.S. generic drugs market size is expected to be worth around 196.90 billion by 2034, increasing from USD 138.24 billion in 2024, representing a healthy CAGR of 3.6% ...

Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...